Piramal Pharma Limited (PPL) is part of the Piramal group of companies. The company operates through 3 major segments(1) Contract development and manufacturing organisations (CDMO), (2) Complex hospital generics (critical care), and (3) consumer healthcare (OTC).Company entered Pharma space back in 1988 with acquisition of Nicholas Laboratories and grew through a series of Mergers & Acquisitions[1]and various organic initiatives. In 2010 the Domestic formulations business was sold to Abott for $3.7 billion[2]and Diagnostic Services was sold to Super Religare Laboratories (SRL)[3]